Research

Energy balance

Cagrisema produced significantly greater percentage weight loss than semaglutide with a mean difference of -7.47% (95% CI: -10.58, -4.36; p < 0.001).

Cagrisema may be a more effective option for weight loss in obese patients compared to semaglutide.

StrongSupportsmedium confidence
Cagrisema produced significantly greater percentage [MD -7.47% (95% CI: -10.58, -4.36); p < 0.001] weight loss than semaglutide.
Muhammad Ahmed et al. · Diabetes Obesity and Metabolism · 2026

Why this rating

Based on a systematic review and meta-analysis of randomized controlled trials.

Source

Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti‐Obesity Medications: A Systematic Review, Meta‐Analysis and Meta‐Regression

Muhammad Ahmed et al. · Diabetes Obesity and Metabolism · 2026

DOI 10.1111/dom.70667

Meta-analysis
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →